Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant ch
- This topic has 0 replies, 1 voice, and was last updated 5 years, 7 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients.
https://www.ncbi.nlm.nih.gov/pubmed/30242888
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.